These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 16821163)
1. Drug evaluation: The MTP inhibitor JTT-130 as a potential treatment for hyperlipidemia. Burnett JR IDrugs; 2006 Jul; 9(7):495-9. PubMed ID: 16821163 [TBL] [Abstract][Full Text] [Related]
2. JTT-705. Japan Tobacco. Linders JT Curr Opin Investig Drugs; 2004 Mar; 5(3):339-43. PubMed ID: 15083602 [TBL] [Abstract][Full Text] [Related]
3. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models. Mera Y; Kawai T; Ogawa N; Odani N; Sasase T; Miyajima K; Ohta T; Kakutani M J Pharmacol Sci; 2015 Nov; 129(3):169-76. PubMed ID: 26598005 [TBL] [Abstract][Full Text] [Related]
4. Drug evaluation: TAK-475--an oral inhibitor of squalene synthase for hyperlipidemia. Burnett JR Curr Opin Investig Drugs; 2006 Sep; 7(9):850-6. PubMed ID: 17002264 [TBL] [Abstract][Full Text] [Related]
12. Dibenzodioxocinones--a new class of CETP inhibitors. Brückner D; Hafner FT; Li V; Schmeck C; Telser J; Vakalopoulos A; Wirtz G Bioorg Med Chem Lett; 2005 Aug; 15(15):3611-4. PubMed ID: 15975789 [TBL] [Abstract][Full Text] [Related]
13. Drug therapy for hyperlipidemia. Am Pharm; 1988 Mar; NS28(3):91-5. PubMed ID: 3285656 [No Abstract] [Full Text] [Related]
14. [Microsomal triglyceride transfer protein inhibitor]. Sugimoto T; Yamashita S Nihon Rinsho; 2001 Mar; 59 Suppl 3():665-70. PubMed ID: 11347150 [No Abstract] [Full Text] [Related]
15. Prospects for the development of novel anti-hyperlipidemic drugs. Derosa G; Salvadeo S; Cicero AF Curr Opin Investig Drugs; 2006 Sep; 7(9):826-33. PubMed ID: 17002261 [TBL] [Abstract][Full Text] [Related]
16. [Microsomal triglyceride transfer protein (MTP)]. Yamashita S Nihon Rinsho; 2001 Feb; 59 Suppl 2():226-35. PubMed ID: 11351580 [No Abstract] [Full Text] [Related]
17. Bis[3-(4'-substituted phenyl)prop-2-ene]disulfides as a new class of antihyperlipidemic compounds. Sharma M; Tiwari M; Chandra R Bioorg Med Chem Lett; 2004 Nov; 14(21):5347-50. PubMed ID: 15454225 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of non-heparin glycosaminoglycans of natural origin. Bianchini P Semin Thromb Hemost; 1989 Oct; 15(4):365-9. PubMed ID: 2683090 [No Abstract] [Full Text] [Related]